Marie-Ange Demoitie

Title: Marie-Ange Demoitie: Innovator in Immunology

Introduction

Marie-Ange Demoitie is a prominent inventor based in Rixensart, Belgium. She has made significant contributions to the field of immunology, particularly in developing methods for inducing immune responses against mycobacterial infections. With a total of 2 patents, her work is recognized for its potential impact on vaccine development and disease prevention.

Latest Patents

Marie-Ange Demoitie's latest patents include innovative methods for inducing an immune response. One patent focuses on methods that involve administering a polypeptide Rv1196 related antigen alongside an adenovirus encoding the same antigen. Another patent outlines methods for inducing an immune response through at least two administrations of an immunogenic composition containing an M72 related antigen, with a delayed subsequent administration. These inventions highlight her commitment to advancing immunological research.

Career Highlights

Marie-Ange Demoitie is associated with GlaxoSmithKline Biologicals SA, where she has been instrumental in research and development efforts. Her work has contributed to the understanding of immune responses and the development of new therapeutic strategies. Her expertise in the field has positioned her as a valuable asset in the pharmaceutical industry.

Collaborations

Marie-Ange has collaborated with notable colleagues, including Marie-Noelle Renelle Donner and Nadia Ouaked. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in immunology.

Conclusion

Marie-Ange Demoitie is a distinguished inventor whose work in immunology has the potential to transform approaches to disease prevention. Her patents and collaborations reflect her dedication to advancing scientific knowledge and improving public health.